Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.

Author: Abou-SettaA M, Al-InanyH G, FarquharC M

Paper Details 
Original Abstract of the Article :
Various options exist for treating endometriosis, including ovarian suppression therapy, surgical treatment or a combination of these strategies. Surgical treatment of endometriosis sets out to remove visible areas of endometriosis and restore anatomy by division of adhesions. The aim of medical the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD005072.pub2

データ提供:米国国立医学図書館(NLM)

Levonorgestrel-Releasing Intrauterine Device (LNG-IUD) for Symptomatic Endometriosis Following Surgery

Endometriosis is a condition that can be as perplexing as a mirage in the desert. It’s a condition where tissue similar to the lining of the uterus grows outside the uterus, causing pain and other symptoms. This study explores the effectiveness of the [levonorgestrel-releasing intrauterine device (LNG-IUD)] in managing [symptomatic endometriosis] after surgery.

The authors acknowledge that various treatment options exist for endometriosis, including [ovarian suppression therapy] and surgical treatment. The study focuses on the potential benefit of postoperative treatment with the LNG-IUS, suggesting it as a viable strategy for managing the condition after surgery. The researchers highlight that while the primary goal of surgery is to remove visible areas of endometriosis and restore anatomy, medical therapy aims to inhibit the growth of endometriotic implants by suppressing ovarian steroids.

A Promising Postoperative Treatment Option

The study suggests that the LNG-IUS could be a valuable addition to the treatment arsenal for endometriosis. This device, with its controlled release of [levonorgestrel], offers a potential solution for managing symptoms after surgery and potentially preventing recurrence.

Implications for Women's Health and Quality of Life

The use of LNG-IUS could significantly improve the quality of life for women suffering from endometriosis. By reducing pain and other symptoms, the device could empower women to live fuller and more active lives. This is particularly important given that endometriosis can have a profound impact on women’s physical and emotional well-being.

Dr.Camel's Conclusion

This study offers a promising new approach to managing endometriosis, a condition that can be a real desert of discomfort for women. While more research is needed to fully understand the long-term effects of LNG-IUS, this device holds great promise for providing effective relief and improving the lives of women with endometriosis.

Date :
  1. Date Completed 2007-01-19
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

17054236

DOI: Digital Object Identifier

10.1002/14651858.CD005072.pub2

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.